Investor Relations
Feb 05, 2019
OPKO Health, Inc. Announces the Pricing of its Offering of Convertible Senior Notes MORE >>
Feb 04, 2019
OPKO Health, Inc. Announces Proposed Offering of Convertible Senior Notes MORE >>
Feb 01, 2019
OPKO Health Receives FDA Approval for the Point-of-Care Sangia PSA Test with the Claros® 1 Analyzer MORE >>
Jan 31, 2019
OPKO Provides Update on the Development of OPK-88004, a Selective Androgen Receptor Modulator MORE >>

SEC Filings

Form Description Filing date View
S-8

Securities offered to employees pursuant to employee benefit plans

View HTML
POS AM

Post-effective amendment to an S-Type filing

View HTML
10QSB

Quarterly report filed by small businesses

View HTML
POS AM

Post-effective amendment to an S-Type filing

View HTML
10QSB

Quarterly report filed by small businesses

View HTML
10KSB/A

Amendment to a previously filed 10KSB

View HTML
DEF 14A

Official notification to shareholders of matters to be brought to a vote ("Proxy")

View HTML
POS AM

Post-effective amendment to an S-Type filing

View HTML
S-3

Simplified registration form

View HTML
10KSB40

Optional form for annual and transition reports of small business issuers

View HTML
10QSB

Quarterly report filed by small businesses

View HTML
SB-2

Optional form for the registration of securities to be sold to the public by small business issuers

View HTML
S-8

Securities offered to employees pursuant to employee benefit plans

View HTML
10-Q

Quarterly report which provides a continuing view of a company's financial position

View HTML
SB-2/A

Pre-effective amendment to an SB-2 filing

View HTML
10QSB

Quarterly report filed by small businesses

View HTML